RGEN is trading at 180.66 in a Stage 2 advancing phase, holding above a rising 30-week moving average with a 7.68% slope over six weeks and passing 7 of 8 trend template checks. The market is focused on a short 15.8% three-week consolidation that has not yet matured into a fully formed base, with a pivot at 194.57 and price about 7.1% off its 52-week high. Overall sentiment is bullish, reflecting an offensive setup, though the base remains too brief for a VCP and volume is not yet drying up.
Continue Reading
The full scanned list, new entries and chart analysis are for pass holders.
365-Day Pass$120.00
Already a pass holder? Sign in · Continue with Google
Discover more from CANSLIM Research
Subscribe to get the latest posts sent to your email.